Infection Control Market Report Scope & Overview:

The Infection Control Market was estimated at USD 267.3 billion in 2025 and is expected to reach USD 503.7 billion by 2035 and grow at a CAGR of 6.66% over the forecast period of 2026-2035.

Infection Control Market is witnessing growth owing to high prevalence rates of infections acquired by patients in the hospitals and increased focus towards patient safety and hygienic conditions in healthcare institutions. The growing number of surgeries, development in the healthcare infrastructure, and an increase in the number of patients visiting the hospitals have contributed to the increasing demand for sterilizers and disinfectants. Moreover, stringent regulations, improved awareness levels, and technological innovations like UV disinfection and automated sterilization systems have propelled the market growth.

Hospital-acquired infections affect approximately 1 in 25 patients on any given day in U.S. hospitals, according to CDC data, resulting in 1.7 million infections and 99,000 deaths annually. The clinical and economic cost of HAIs, estimated at USD 28-45 billion per year in the U.S. alone, creates a powerful financial incentive for healthcare systems to invest in comprehensive infection control programs.

Market Size and Forecast

• Market Size in 2025: USD 267.3 Billion

• Market Size by 2035: USD 503.7 Billion

• CAGR: 6.66% from 2026 to 2035

• Base Year: 2025

• Forecast Period: 2026–2035

• Historical Data: 2022–2024

To Get more information on Infection Control Market - Request Free Sample Report

Infection Control Market Trends

• AI-powered UV-C disinfection robots automating high-level room disinfection between patients and demonstrating superior efficacy over manual cleaning.

• Hydrogen peroxide vapor (HPV) sterilization expanding as a validated low-temperature method for heat-sensitive medical devices.

• Single-use disposable medical instruments reducing reprocessing costs and eliminating cross-contamination risks.

• Advanced antimicrobial surface coatings being incorporated into high-touch surfaces in healthcare facilities.

• Digital tracking systems monitoring hand hygiene compliance and sterilization cycle validation across healthcare facilities.

• Eco-friendly and biodegradable disinfectants replacing traditional bleach-based products as environmental consciousness grows.

• Wearable infection control monitoring devices for healthcare workers tracking PPE compliance and exposure events.

The U.S. Infection Control Market was valued at USD 67.6 billion in 2025 and is expected to reach USD 125.5 billion by 2035, at a CAGR of 6.40% from 2026 to 2035.

The United States Infection Control Market is expected to grow because of the high incidence rate of hospital infections and strict adherence to patient safety regulations. The development of healthcare infrastructure, stringent compliance to regulations, and extensive use of sterilization products are contributing to market growth. An increase in the number of surgeries and healthcare expenditure is also propelling the growth of the market.

The U.S. Department of Health and Human Services through BARDA increased its 2024 allocation for infection prevention research, providing momentum for innovative new sterilization and disinfection technologies that are expanding the capabilities of the infection control product portfolio beyond traditional chemical disinfection methods.

Infection Control Market Segment Analysis

• By Type, Consumables segment dominated the Infection Control Market in 2025 with ~47% share; Services segment fastest growing (CAGR).

• By End Use, Hospitals segment dominated the Infection Control Market in 2025 with ~58% share; Clinical Laboratories segment fastest growing (CAGR).

By Type, Consumables segment dominates the Infection Control Market, Services segment expected to grow fastest

Consumables led the Infection Control Market in 2025 owing to the regular and large-scale use of disinfectants, sterilization products, personal protective equipment (PPE), gloves, masks, and other cleaning products. These products are critical for the prevention of hospital acquired infections and maintenance of hygiene standards in clinical processes. Effective infection prevention practices, an increase in the number of surgeries, and improved hygiene practices have also boosted the growth of the Consumables segment in healthcare environments around the world.

The Services segment is the fastest growing because of the rising trend towards outsourcing infection control solutions, sterilization solutions, infection prevention training, and compliance solutions. The need for efficient infection control solutions among healthcare organizations and rising prevalence of hospital-acquired infections are expected to fuel the demand for infection control services.

By End Use, Hospitals segment dominates the Infection Control Market, Clinical Laboratories segment expected to grow fastest

The Hospitals segment led the Infection Control Market in 2025 owing to the higher flow of patients, complicated treatments, and increased risks of healthcare-acquired infections. Infection control is necessary in hospitals because of sterilization processes, surface disinfection, and the use of protective equipment to protect both patients and hospital staff from any harm. Higher volumes of surgeries, expansion of the healthcare industry, and stringent regulations governing the prevention of infection cases have boosted the presence of hospitals in this market.

Clinical Laboratories is the fastest-growing segment as a result of increasing testing volumes and the adoption of diagnostics. The growth in testing volumes post-health emergencies and the importance of implementing effective infection control practices to manage infection cases in laboratories have boosted the presence of clinical laboratories in the market.

Regional Insights

North America Infection Control Market

The North American region accounted for the largest market share, at 39.09%, of the Infection Control Market in 2025 because of its highly developed healthcare facilities and greater usage of sterilization and disinfection products. The region follows strict rules regarding hospital sanitation and infection prevention, which increases the demand for infection control products. Growing cases of hospital-acquired infections, along with growing numbers of surgeries, also contribute to the growth of the Infection Control Market.

Get Customized Report as per Your Business Requirement - Enquiry Now

Asia Pacific Infection Control Market

Asia Pacific is anticipated to witness the highest CAGR until 2035 in the Infection Control Market on account of the swift development of healthcare infrastructure and increased consciousness regarding hospital hygiene. An increase in cases of nosocomial infections, growth in surgeries, and medical tourism is fueling demand. Governments are focused on developing state-of-the-art healthcare infrastructure and implementing initiatives for infection control. Furthermore, the adoption of sophisticated sterilization techniques, disinfectants, and disposable medical devices is also boosting the growth of the market.

Europe Infection Control Market

The Europe Infection Control Market is recording consistent growth because of stringent healthcare laws and the focus on patient safety and hygiene. Growing cases of hospital-acquired infections, as well as an increasing number of surgeries, have led to the demand for improved sterilization and disinfection products. The use of automated cleaning systems, ultraviolet disinfection, and high-level disinfectants is contributing to market growth. Moreover, robust healthcare facilities, heavy spending on healthcare, and technological innovations in infection control products are boosting market growth in Europe.

Middle East & Africa and Latin America Infection Control Market

The MEA and Latin America Infection Control Market is steadily increasing owing to the increased investment in healthcare and the development of hospitals’ infrastructure. Increased awareness about infection control methods has increased the demand for sterilization devices, disinfectants, and disposable medical products. The increasing prevalence of nosocomial infections and expansion of surgical procedures have further boosted the adoption rate. However, lack of access to healthcare services and financial limitations in some regions hamper the growth of the market.

Infection Control Market Growth Drivers

• Rising prevalence of hospital-acquired infections and antimicrobial resistance driving continuous demand for advanced infection prevention and sterilization solutions globally

The rising number of patients suffering from HAIs and the increasing number of cases of antimicrobial resistance are contributing significantly to the growing demand for infection control solutions. The increased number of patient admissions and advanced surgeries have made infection prevention imperative, thus making sterilization equipment, disinfection agents, and protective products more necessary. Governments are increasingly imposing stringent rules on hospitals to comply with hygiene standards, thereby promoting the use of sterilization equipment, disinfection products, and protective products. Additionally, heightened knowledge among medical practitioners about infection control practices is also fostering the adoption of modern infection control solutions.

Infection Control Market Restraints

• High operational and maintenance costs of advanced sterilization systems limiting adoption in small and resource-constrained healthcare facilities

The high cost of implementing advanced infection control devices like sterilizers, disinfectants, and monitoring systems is a hindrance for their implementation in small-scale health care organizations that have limited funding. The costs involved in installing and maintaining the technology pose a financial challenge, especially in developing nations. Small health care centers find it difficult to afford automatic sterilizing machinery and other advanced infection control methods. Moreover, there are ongoing costs of consumables like disinfectants and disposable personal protective equipment. Financial constraints and non-reimbursement pose major barriers to the widespread adoption of these technological advancements.

Infection Control Market Opportunities

• Growing demand for single-use medical devices and disposable hygiene products accelerating expansion of infection control product portfolios globally

The growing tendency for disposable medical equipment and hygiene items is providing a great opportunity within the infection control market. Health institutions have adopted the use of disposable gloves, gowns, surgical drapes, and medical tools to avoid cross-infection threats. This preference is common in surgical and emergency departments, where infection control is essential. Patient safety issues and compliance regulations are encouraging their adoption as well. There is a growing need for out-patient and home-based health care, which is aiding in this development. Companies are making efforts to manufacture affordable, environmental-friendly disposables, thus providing room for innovations.

Recent Developments

• 2025: STERIS PLC launched an enhanced automated endoscope reprocessor with real-time cycle documentation, integrated quality control monitoring, and cloud-based compliance reporting that significantly reduces manual documentation burden and improves traceability for regulatory inspections.

• 2024: STERIS introduced an enhanced vaporized hydrogen peroxide sterilization system with faster cycle times and improved efficacy against multidrug-resistant bacteria including C. difficile spores, addressing the most challenging HAI pathogens in hospital environments.

Key Players

• 3M Company

• STERIS plc

• Getinge AB

• Belimed AG

• Advanced Sterilization Products (ASP)

• Ecolab Inc.

• Cantel Medical Corp.

• Metrex Research, LLC

• Tuttnauer Ltd.

• MMM Group

• Steelco S.p.A.

• Contec Inc.

• Schülke & Mayr GmbH

• Reckitt Benckiser Group plc

• Diversey Holdings Ltd.

• Pal International Ltd.

• Sotera Health Company

• Skytron LLC

• Matachana Group

• Case Medical, Inc.